| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.5 |